Schlieren
,
Switzerland
Limmattal Hospital
A general hospital with bespoke wireless access control
Helseløsninger
Optimized routes and access authorization
As a general hospital with training assignments, Limmattal Hospital in Switzerland provides basic medical care to more than 77,000 patients annually. With multiple buildings connected by bright, spacious inner courtyards, integrated access solutions ensure barrier-free movement for staff, patients and visitors. At the same time, access is restricted to authorized personnel only, thereby guaranteeing infection control.
Customer requirements
How do we adapt smart, scalable, integrated access solutions to specific requirements?
- A high degree of flexibility and consistency between software and hardware combine to create a tailor-made solution
- Customer-centered consulting for optimized application of products and solutions
- Coordination and control of people flows, incl. employees, patients, visitors and suppliers
- Access control to different hospital sections and zones for smooth daily business
- Flexibility in the use of space and rescaling of the software
No items found.
A comprehensive system for integrated access to health care facilities
- The dormakaba exos 9300 system coordinates access rights across multiple locations.
- The modular slide channel door closer system offers various options for barrier-free construction.
- Electronic fitting solutions for demand-driven access control on external doors or doors with increased security requirements.
- The c-lever air fitting can be integrated into all dormakaba solutions and supports the latest RFID technologies.
- The compact reader 91 10 can be used as part of any access solution.
Testimonial
.webp)
How can we help?
Kontakta oss
ALL:https://dormakaba.us20.list-manage.com/subscribe/post?u=e027e9a37aaed4adfa7bb9592&id=204d16f022&f_id=0037f8e6f0
GB:https://go.pardot.com/l/874911/2021-09-24/qwrqv
US:https://www2.dormakaba.com/l/682623/2022-07-12/7y4gc
CN:https://www2.apac.dormakaba.com/l/1004121/2023-02-17/7m8m
DE:https://www2.emea.dormakaba.com/l/952052/2022-07-12/332q4
AT:https://www2.emea.dormakaba.com/l/952052/2022-07-12/332q4
CH:https://www2.emea.dormakaba.com/l/952052/2022-07-12/332q4
BE:https://www2.emea.dormakaba.com/l/952052/2022-07-12/332q4
ES:https://www2.emea.dormakaba.com/l/952052/2022-07-12/332q4
PT:https://www2.emea.dormakaba.com/l/952052/2022-07-12/332q4
SE:https://www2.emea.dormakaba.com/l/952052/2022-07-12/332q4
NO:https://www2.emea.dormakaba.com/l/952052/2022-07-12/332q4
FI:https://www2.emea.dormakaba.com/l/952052/2022-07-12/332q4
DK:https://www2.emea.dormakaba.com/l/952052/2022-07-12/332q4
SG:https://dormakaba.us20.list-manage.com/subscribe/post?u=e027e9a37aaed4adfa7bb9592&id=204d16f022&f_id=0037f8e6f0
MY:https://dormakaba.us20.list-manage.com/subscribe/post?u=e027e9a37aaed4adfa7bb9592&id=204d16f022&f_id=0037f8e6f0
ID:https://dormakaba.us20.list-manage.com/subscribe/post?u=e027e9a37aaed4adfa7bb9592&id=204d16f022&f_id=0037f8e6f0
PH:https://dormakaba.us20.list-manage.com/subscribe/post?u=e027e9a37aaed4adfa7bb9592&id=204d16f022&f_id=0037f8e6f0
TH:https://dormakaba.us20.list-manage.com/subscribe/post?u=e027e9a37aaed4adfa7bb9592&id=204d16f022&f_id=0037f8e6f0
DEFAULT:https://dormakaba.us20.list-manage.com/subscribe/post?u=e027e9a37aaed4adfa7bb9592&id=204d16f022&f_id=0037f8e6f0
GB:https://go.pardot.com/l/874911/2021-09-24/qwrqv
US:https://www2.dormakaba.com/l/682623/2022-07-12/7y4gc
CN:https://www2.apac.dormakaba.com/l/1004121/2023-02-17/7m8m
DE:https://www2.emea.dormakaba.com/l/952052/2022-07-12/332q4
AT:https://www2.emea.dormakaba.com/l/952052/2022-07-12/332q4
CH:https://www2.emea.dormakaba.com/l/952052/2022-07-12/332q4
BE:https://www2.emea.dormakaba.com/l/952052/2022-07-12/332q4
ES:https://www2.emea.dormakaba.com/l/952052/2022-07-12/332q4
PT:https://www2.emea.dormakaba.com/l/952052/2022-07-12/332q4
SE:https://www2.emea.dormakaba.com/l/952052/2022-07-12/332q4
NO:https://www2.emea.dormakaba.com/l/952052/2022-07-12/332q4
FI:https://www2.emea.dormakaba.com/l/952052/2022-07-12/332q4
DK:https://www2.emea.dormakaba.com/l/952052/2022-07-12/332q4
SG:https://dormakaba.us20.list-manage.com/subscribe/post?u=e027e9a37aaed4adfa7bb9592&id=204d16f022&f_id=0037f8e6f0
MY:https://dormakaba.us20.list-manage.com/subscribe/post?u=e027e9a37aaed4adfa7bb9592&id=204d16f022&f_id=0037f8e6f0
ID:https://dormakaba.us20.list-manage.com/subscribe/post?u=e027e9a37aaed4adfa7bb9592&id=204d16f022&f_id=0037f8e6f0
PH:https://dormakaba.us20.list-manage.com/subscribe/post?u=e027e9a37aaed4adfa7bb9592&id=204d16f022&f_id=0037f8e6f0
TH:https://dormakaba.us20.list-manage.com/subscribe/post?u=e027e9a37aaed4adfa7bb9592&id=204d16f022&f_id=0037f8e6f0
DEFAULT:https://dormakaba.us20.list-manage.com/subscribe/post?u=e027e9a37aaed4adfa7bb9592&id=204d16f022&f_id=0037f8e6f0
GB
US
CN
DE
AT
CH
BE
ES
PT
SE
NO
FI
DK
SG
MY
ID
PH
IT
TH
OTHER
US
CN
DE
AT
CH
BE
ES
PT
SE
NO
FI
DK
SG
MY
ID
PH
IT
TH
OTHER
Skicka
Konfiguration av formulärmall
Innehållet är endast synligt i redigeringsläge
Kampanjnamn:
access³ av dormakaba
Ämne:
Välkommen till access³
Kropp:
access³ av dormakaba
Tack, *|FIRSTNAME|*!
Vi uppskattar ditt intresse för åtkomstplaneringsstöd från dormakaba. Vi har fått ditt meddelande och våra arkitektkonsulter kommer att kontakta dig så snart som möjligt. Tills dess kan du maila oss på planning.support@dormakaba.com
Ha en bra dag,
Ditt dormakaba-team
Juridisk sektion
Detta e-postmeddelande skickades till
*|EMAIL|*!
Från
Dormakaba International Holding AG
Hofwisenstrasse 24
8153 Rümlang, Schweiz
Bild:
https://cdn.prod.website-files.com/61548a6b1afe0972e4fda446/6481b23d468140038c147090_email-access3.jpg
Meddelande E-post:
ALWAYS:planning.support@dormakaba.com;
SG:info.asean@dormakaba.com;
MY:info.my@dormakaba.com;
ID:info.id@dormakaba.com;
PH:info.ph@dormakaba.com;
IT:lisa.cruciani@dormakaba.com;
TH:sales.th@dormakaba.com
SG:info.asean@dormakaba.com;
MY:info.my@dormakaba.com;
ID:info.id@dormakaba.com;
PH:info.ph@dormakaba.com;
IT:lisa.cruciani@dormakaba.com;
TH:sales.th@dormakaba.com